Early diagnosis in oncology is important for treatment by surgical intervention, which
generally has the highest curative potential. For higher stages of disease involvement …

Positron-emission tomography (PET) with 18-fluorodeoxyglucose has a role in the diagnosis
and staging of lung cancer, but is also appealing for assessment of prognosis and treatment …

Conventional chest radiography, computed tomography (CT), magnetic resonance (MR) and
positron emission tomography (PET) are all imaging techniques used for the detection …

Lung cancer is the leading cause of cancer mortality in the United States, with more than
170,000 individuals diagnosed each year and more than 140,000 succumbing to the …

Lung cancer is the leading cause of cancer-related deaths around the world, the most
common type of which is non-small-cell lung cancer (NSCLC). Computed tomography (CT) …

Positron emission tomography (PET)-computed tomography (CT) has become a routine
imaging modality in body oncology and is particularly well suited for the management of …

In the past 5 years, metabolic imaging with positron emission tomography (PET) using 18F-
fluoro-2-deoxy-glucose (FDG) has become an important imaging modality in lung cancer …

Positron emission tomography (PET) represents a dramatic advance in the imaging of lung
cancer. It is valuable for the diagnosis, staging, prognosis, and restaging of disease, and is …

Lung cancer is the leading cause of cancer-related death in industrialized countries. The
overall mortality rate for lung cancer is high, and early diagnosis provides the best chance …

Background Positron emission tomography (PET) scanningis used increasingly to detect
and stage lung cancer, but the testperformance characteristics and relationship of PET to …